北達科他州 的 頭頸部鱗狀細胞癌 臨床試驗
6 項針對 頭頸部鱗狀細胞癌 的研究正在 北達科他州 各地點尋找參與者。
北達科他州 的城市
官方研究文本（英文）
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06992427Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06589804BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Sanford Bismarck Medical Center, Bismarck
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford Broadway Medical Center, Fargo
- 還有 2 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT05136196Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Sanford Bismarck Medical Center, Bismarck
- Sanford Roger Maris Cancer Center, Fargo
招募中2 期
18 至 79 歲 · 所有性別 · 更新於 2026年9月22日 · NCT04671667Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Sanford Bismarck Medical Center, Bismarck
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford South University Medical Center, Fargo
- 還有 3 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月14日 · NCT02734537A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Sanford Fargo, Fargo
招募中觀察性研究
18 歲及以上 · 所有性別 · 更新於 2026年9月3日 · NCT06163534資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。